View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Lakeland Fire + Safety Appoints Calven Swinea as Chief Financial Offic...

Lakeland Fire + Safety Appoints Calven Swinea as Chief Financial Officer Financial and Accounting Veteran Leading ERP Implementation and Next Phase of Company Growth HUNTSVILLE, Ala., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. ("Lakeland Fire + Safety" or "Lakeland") (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced the appointment of Calven Swinea as Chief Financial Officer, effectively immediately. Mr. Swinea was appointed Interim Chief Financial Officer, effective January 202...

 PRESS RELEASE

Lakeland Fire + Safety's Jolly Scarpe Delivers Urgent Boot Order to It...

Lakeland Fire + Safety's Jolly Scarpe Delivers Urgent Boot Order to Italian Government for Winter Olympic Games Full Stock Availability Enabled Delivery in Under 48 Hours to Olympic Locations HUNTSVILLE, Ala., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. ("Lakeland Fire + Safety" or "Lakeland") (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced the shipment and delivery of an urgent order through its Jolly Scarpe brand from the Italian Ministry of the Interior - Department of Publi...

 PRESS RELEASE

Lakeland Fire + Safety Awarded Contract from UK County Fire and Rescue...

Lakeland Fire + Safety Awarded Contract from UK County Fire and Rescue Services for Firefighting Gloves Multi-Year Agreement Highlights Ability to Meet Increasingly Rigorous Procurement Standards HUNTSVILLE, Ala., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. ("Lakeland Fire + Safety" or "Lakeland") (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced that its Eagle FR subsidiary has been awarded a significant multi-year contract to supply Ultimate Glow+ structural firefighting glove...

 PRESS RELEASE

Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement...

Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency WVE-006 is a first-in-class RNA editing therapeutic candidate designed to correct the root cause of disease for the 200,000 individuals in the U.S. and Europe living with AATD; no currently approved therapies address both lung and liver manifestations of this disease Wave plans to engage FDA on potential accelerated approval pathway for WVE-006, with regulatory feedback anticipated mid-2026 Data from the 400 mg multidose cohort of RestorAATion-2 clinical...

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SRPT SAREPTA THERAPEUTICS INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
PANW PALO ALTO NETWORKS INC.
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
NFLX NETFLIX INC.
FRX_CN FENNEC PHARMACEUTICALS
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
WVE WAVE LIFE SCIENCES
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
OVID OVID THERAPEUTICS
ISR ISORAY
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
GOSS GOSSAMER BIO
STOK STOKE THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ZNTL KEROS THERAPEUTICS
BEAM ZENTALIS PHARMACEUTICALS
LRMR BEAM THERAPEUTICS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
DASH TRAVERE THERAPEUTICS INC
VRDN DOORDASH
PLTK VIRIDIAN THERAPEUTICS INC
RBLX PLAYTIKA HOLDING
DAWN ROBLOX
STX DAY ONE BIOPHARMACEUTICALS INC
APP SEAGATE TECHNOLOGY HLDGS PLC
GFS APPLOVIN CORP
GMTX GLOBALFOUNDRIES INC
TYRA GEMINI THERAPEUTICS INC
EWTX TYRA BIOSCIENCES INC
SLDB EDGEWISE THERAPEUTICS INC
APGE SOLID BIOSCIENCES INC
DNTH APOGEE THERAPEUTICS INC
CGON DIANTHUS THERAPEUTICS INC
ORKA CG ONCOLOGY INC
BCAX ORUKA THERAPEUTICS INC
ZBIO BICARA THERAPEUTICS INC.
TLX ZENAS BIOPHARMA INC.
MAZE TELIX PHARMACEUTICALS LIMITED
JBIO MAZE THERAPEUTICS INC
JADE BIOSCIENCES INC
David Nierengarten ... (+8)
  • David Nierengarten
  • Dennis Pak
  • Geoffrey Von Der Ahe
  • Laura Chico
  • Martin Fan
  • Robert Driscoll
  • Thomas Yip
  • Yun Zhong
 PRESS RELEASE

Lakeland Fire + Safety Secures Tender from Belgian Federal and Local P...

Lakeland Fire + Safety Secures Tender from Belgian Federal and Local Police Departments for Safety Footwear Third Award in Six-Year Tender Agreement Demonstrates Global Reach Across Industry Verticals HUNTSVILLE, Ala., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. ("Lakeland Fire + Safety" or "Lakeland") (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced it has received an order from the Belgian Federal Police and Local Police departments for certified safety footwear. Terms of th...

 PRESS RELEASE

Lakeland Fire + Safety Issues Shareholder Letter and Provides Corporat...

Lakeland Fire + Safety Issues Shareholder Letter and Provides Corporate Update HUNTSVILLE, Ala., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. ("Lakeland Fire + Safety" or "Lakeland") (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today issued a letter to shareholders from Jim Jenkins, President, Chief Executive Officer and Executive Chairman. Dear Lakeland Shareholders, Lakeland Fire + Safety’s fiscal year 2026, which ends January 31st, was underscored by both opportunities and challenges. Wh...

Wedbush Research
  • Wedbush Research
 PRESS RELEASE

Lakeland Fire + Safety Achieves NFPA 1970 Certification for Ultimate G...

Lakeland Fire + Safety Achieves NFPA 1970 Certification for Ultimate Glow+ Leather Firefighting Gloves-NFPA 321 Series Milestone Marks the First NFPA 1970 Certificated Product in Lakeland Fire + Safety’s Portfolio HUNTSVILLE, Ala., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. ("Lakeland Fire + Safety" or "Lakeland") (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced that its Lakeland Ultimate Glow+ Leather Firefighting Gloves-NFPA 321 Series has officially achieved NFPA 1970:2025 c...

 PRESS RELEASE

Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44t...

Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio Wave expects to initiate a Phase 2a multidose portion of WVE-007 INLIGHT clinical trial in individuals living with obesity with higher BMI and comorbidities in 1H 2026, and initiate new trials of WVE-007 as an add-on to incretin and as post-incretin maintenance in 2026 Initial WVE-007 240 mg single-dose data reported in 2025 demonstrated improved body composition with fat l...

Yun Zhong
  • Yun Zhong

Clinical Data From Fellow INHBE Program Provide Strong POC

ARO-ALK7 Shows Promising mRNA Knockdown and Fat Reduction. ALK7 is an Activin receptor that is encoded by the ACVR1C gene and expressed in adipose tissue. ARWR reported placebo-adjusted visceral fat reduction of 14.1% from a single dose of 200mg at week 8. According to ARWR, the ARO-ALK7 program is

 PRESS RELEASE

Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Co...

Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 13, 2026 at 2:15 p.m. PT / 5:15 p.m. ET. A live webcast of the presentation can be accessed by visiti...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch